Regenexx-ACL – Non-Surgical Stem Cell Injection Alternative to Surgery

Regenexx-ACL – Non-Surgical Stem Cell Injection Alternative to Surgery


[MUSIC PLAYING] The ACL, or anterior
cruciate ligament, is an important
stabilizer of the knee for front to back movements
and in twisting motions. It is most commonly injured
while playing sports. Most patients think that
replacing a torn ACL is like getting a part
replaced in their car. However, the research
on ACL surgeries paints a different story. Most athletes who
had ACL surgery never regained their
normal balance and control over that knee. Plus, athletes
are six times more likely to reinjure the same ACL
or opposite ACL within a year of their initial surgery. Four years after surgery,
patients who had ACL surgery has no more function and no less
arthritis than those patients who didn’t have the surgery. Why is all of this happening? Largely because
the new surgically installed ACL isn’t at all
like the original equipment. First, it must go in at
a much steeper angle. So it can never provide
the same kind of front to back stabilization
of the original ACL. The surgically
installed ACL also doesn’t have the same
intact nerve supply, which is needed to
fine-tune normal balance and motion of the knee. But for many who suffer from an
ACL injury, there’s good news. Regenexx ACL is a
nonsurgical procedure that utilizes the stem
cells from your own body to assist healing of ACL tears. Rather than a surgical
amputation and replacement of your ACL, it’s an exacting
image-guided injection of stem cells into
your ACL tear. In our registry-based
study, we were able to see good healing
of the ACL in followup MRIs in more than seven
in 10 patients. And 75% of patients returned
to their favorite sports without the need for surgery. So if you’ve experienced
an ACL injury, consider the Regenexx
ACL procedure and let your own stem cells
help you get back in the game and on the path
to better health.

Add a Comment

Your email address will not be published. Required fields are marked *